ST. HELIER, Jersey--(BUSINESS WIRE)--Novocure (NASDAQ:NVCR) announced today results from a retrospective post-hoc analysis of its phase 3 pivotal EF-14 trial data showing that increased compliance ...

Jeffrey Weiss is fitted with an Optune device as part of his treatment for glioblastoma at his home in North Dallas on April 12. Louis DeLuca / Staff Photographer I'm now more than six months into the ...

Tumor-treating fields (TTFields) are a relatively new form of cancer treatment that send mild electrical fields through the scalp in an effort to block cell division. While it was approved a few years ...

CHICAGO — A medical device made by Novocure that creates electric fields in the lungs via wearable skin patches extended the survival of patients with lung cancer in a clinical trial, researchers ...

Shares soar in response to the release of positive clinical updates. NovoCure gave a series of clinical updates that got the markets excited. First, the company reported data from its phase 2 Panova ...

ST. HELIER, Jersey--(BUSINESS WIRE)--Novocure (NASDAQ:NVCR) announced today that the Swiss Federal Office of Public Health (BAG) has added Optune in combination with temozolomide to the List of ...

CINCINNATI (WKRC) - A breakthrough device is providing new hope for brain cancer survivors, as demonstrated by the inspiring journey of Patty Young. Diagnosed with a brain tumor after suffering a ...

Shares of this oncology-focused medical device company continue their electrifying run. For context, the S&P 500 returned 1.4% last month. NovoCure stock has been on a tear in 2019, with shares up 157 ...